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Epoxide hydrolases play an important role in the biodegradation of organic compounds and are potentially
useful in enantioselective biocatalysis. An analysis of various genomic databases revealed that about 20% of
sequenced organisms contain one or more putative epoxide hydrolase genes. They were found in all domains
of life, and many fungi and actinobacteria contain several putative epoxide hydrolase-encoding genes. Multiple
sequence alignments of epoxide hydrolases with other known and putative /-hydrolase fold enzymes that
possess a nucleophilic aspartate revealed that these enzymes can be classified into eight phylogenetic groups
that all contain putative epoxide hydrolases. To determine their catalytic activities, 10 putative bacterial
epoxide hydrolase genes and 2 known bacterial epoxide hydrolase genes were cloned and overexpressed in
Escherichia coli. The production of active enzyme was strongly improved by fusion to the maltose binding
protein (MalE), which prevented inclusion body formation and facilitated protein purification. Eight of the 12
fusion proteins were active toward one or more of the 21 epoxides that were tested, and they converted both
terminal and nonterminal epoxides. Four of the new epoxide hydrolases showed an uncommon enantiopref-
erence for meso-epoxides and/or terminal aromatic epoxides, which made them suitable for the production of
enantiopure (S,S)-diols and (R)-epoxides. The results show that the expression of epoxide hydrolase genes that
are detected by analyses of genomic databases is a useful strategy for obtaining new biocatalysts.
Enantiopure epoxides and vicinal diols are valuable inter-
mediates in the synthesis of a number of pharmaceutical com-
pounds. Epoxide hydrolases (EC 3.3.2.3) catalyze the conver-
sion of epoxides to the corresponding diols. If they are
enantioselective, they can be used to produce enantiopure
epoxides by means of kinetic resolution (5). In the past, when
only epoxide hydrolases from mammalian sources were known
(12), the use of epoxide hydrolases in biocatalysis was ham-
pered by their poor availability and insufficient catalytic per-
formance, such as a low turnover rate or poor enantioselectivity.
The potential for biocatalytic application of epoxide hydrolases
was significantly increased with the discovery of microbial ep-
oxide hydrolases (41), which are easier to produce in large
quantities. The cloning and overexpression of several enantio-
selective epoxide hydrolases, e.g., from Agrobacterium radio-
bacter (35), Aspergillus niger (3), and potato plants (40), not
only facilitated large-scale production of these enzymes but
also made it possible to improve their biocatalytic properties by
site-directed or random mutagenesis (34, 36, 43).
Since many microbial genome sequences are available in the
public domain, it is useful to screen these databases for genes
that might encode new enzymes with interesting properties.
Novel epoxide hydrolases can be identified by performing a
BLAST search of the genomic databases, using amino acid
sequences of known epoxide hydrolases as queries. This ap-
proach will result in putative epoxide hydrolases but also in
amino acid sequences from structurally and mechanistically
related enzymes, such as esterases and dehalogenases (33),
which can be filtered out using conserved epoxide hydrolase
sequence motifs that define the active site (Fig. 1). The puta-
tive epoxide hydrolase-encoding genes can subsequently be
cloned and overexpressed in a host with no endogenous ep-
oxide hydrolase activity, such as Escherichia coli, and the ac-
tivity of the encoded proteins can be tested.
Most epoxide hydrolases for which sequence information is
presently available are members of the /-hydrolase fold fam-
ily, to which lipases, esterases, and haloalkane dehalogenases
also belong. These enzymes consist of a main domain that is
composed of a central -sheet surrounded by -helices and a
variable cap domain positioned on top of the substrate binding
site (Fig. 1) (33). They use a catalytic mechanism that involves
an Asp/Ser/Cys-His-Asp/Glu (nucleophile-histidine-acid) cata-
lytic triad located on top loops of the main domain. The posi-
tions of these residues are structurally conserved in the order
nucleophile-histidine-acid (Fig. 1A and B) (33), but in the
primary amino acid sequence the order is nucleophile-acid-
histidine, with the acid located either in front of the cap do-
main (Fig. 1C, position 3a) or after the cap domain (Fig. 1C,
position 3b).
In the case of /-hydrolase fold epoxide hydrolases, the
catalytic triad nucleophile is an invariable aspartate that opens
the epoxide ring by nucleophilic attack (Fig. 1A) (4, 35). The
ring-opening reaction is assisted by two conserved tyrosines
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that are located in the cap domain (Fig. 1C) (6, 36). The
resulting alkyl-enzyme intermediate is subsequently hydro-
lyzed by a water molecule that is activated by a histidine that
functions as a proton acceptor and, in turn, is assisted by the
acidic residue (Fig. 1B). The negative charge that develops on
the carbonyl oxygen of the nucleophilic aspartate during hy-
drolysis of the alkyl enzyme intermediate is stabilized by two
backbone amides that are contributed by the residue following
the catalytic nucleophile and residue X in a conserved H-G-
X-P motif (Fig. 1C). This motif is located between strand 3
and helix 1 (Fig. 1C, position 5) and is conserved in haloal-
kane dehalogenases and epoxide hydrolases. Residue X is usu-
ally an aromatic residue in epoxide hydrolases, whereas it is an
asparagine or a glutamate in haloalkane dehalogenases. The
side chain of the amino acid at this position lines the active site
(31, 51). Between the H-G-X-P motif and the catalytic nucleo-
phile, there is a conserved G-X-Sm-X-S/T motif of unknown
function (Fig. 1C, position 6).
This paper describes the screening of various genomic da-
tabases for epoxide hydrolases of the /-hydrolase fold fam-
ily. Based on phylogenetic analysis of the resulting sequences
and comparison to other /-hydrolase fold enzymes that have
FIG. 1. Structure and mechanism of /-hydrolase fold epoxide hydrolases. The active site shown in panels A and B is from the epoxide
hydrolase from A. radiobacter AD1 (EchA) (31, 35, 36). (A) Tyrosine-assisted ring opening of the epoxide by the nucleophilic aspartate.
(B) Hydrolysis of the alkyl-enzyme intermediate by an activated water molecule. (C) General topology and structure of /-hydrolase fold epoxide
hydrolases. I, main domain with /-hydrolase fold; II, cap domain; 1, catalytic nucleophile (D107 in EchA); 2, histidine base (H275); 3, charge
relay acid, which can be positioned at either 3a or 3b (D246 is at position 3b); 4, ring-opening tyrosines (Y152/Y215); 5, H-G-X-P motif (the X
is usually an aromatic residue in epoxide hydrolases [W38]); 6, G-X-Sm-X-S/T motif. The region of helix 4a can be nonhelical or missing in some
epoxide hydrolases. The length of the loop between helixes 6 and 7 can vary considerably. Extensions with additional domains of 40 to 300 amino
acids can occur at both the N and C termini.
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a nucleophilic aspartate, the epoxide hydrolases were divided
into different phylogenetic groups. Ten of these putative ep-
oxide hydrolases, together with two known bacterial epoxide
hydrolases, were cloned and overexpressed in E. coli and sub-
sequently tested for their biocatalytic potential.
MATERIALS AND METHODS
Materials. The epoxides that were used in this study are indicated in Fig. 2.
The same numbering is used for the epoxides and the corresponding diols, with
the extension “a” for the diol. Epoxides 2, 7, 9, 10, 20, and 25 (Fig. 2), racemic
and enantiopure diols 20a and 23a, and L-epinephrine were obtained from Acros
(Geel, Belgium). Epoxide 5 was obtained from Enzis (Groningen, The Nether-
lands), and epoxides 6, 11, 12, 15 to 17, 19, and 23 were obtained from Aldrich.
Furthermore, epoxides 8 and 14 were obtained from Lancaster (Frankfurt am
Main, Germany), epoxides 13, 21, and 24 were obtained from Fluka, epoxide 12
was obtained from Tokyo Kasei, and epoxide 22 was obtained from Sigma.
Epoxides 1, 3, and 4 were synthesized from para-methylbenzaldehyde, para-
chlorobenzaldehyde, and meta-chlorobenzaldehyde, respectively. Chiral high-
performance liquid chromatography (HPLC) columns were obtained from Dia-
cel. A G-TA capillary column was obtained from Altech, and a CP Chirasil Dex
CB column was obtained from Chrompack. All DNA-modifying enzymes and
ampicillin were obtained from Roche Molecular Biochemicals, except for Pwo
DNA polymerase (GENAXIS GmbH) and Pfu DNA polymerase (Stratagene).
Other medium components were obtained from Merck and Difco. The plasmid
vector pMAL-c2x and amylose resin were obtained from New England Biolabs.
E. coli strain TOP10 was obtained from Invitrogen Inc., and strain BL21(DE3)/
pLysS Rosetta was obtained from Novagen. Oligonucleotides were obtained
from Eurosequence or Sigma-Genosys, and IPTG (isopropyl--D-thiogalactopy-
ranoside) was obtained from Eurogentec. The constructs were sequenced at the
Biomedical Centre in Groningen, using the malE (forward) and M13/pUC (re-
verse) primers.
BLAST search, multiple sequence alignments, and phylogenetic analysis. In
order to obtain putative epoxide hydrolase-encoding sequences, we screened
the Pedant (http://pedant.gsf.de), NCBI (http://www.ncbi.nlm.nih.gov), TIGR
(http://www.tigr.org), and Sanger (http://www.sanger.ac.uk) sequence databases
and the Rhodococcus RHA1 genome database ((http://www.rhodococcus.ca).
Epoxide hydrolases for which the activity and sequence are described in the
literature served as query sequences. The resulting BLAST hits were manually
screened for the presence of the putative epoxide hydrolase active-site residues
and the motifs depicted in Fig. 1C. Sequences that contained the catalytic triad,
at least one ring-opening tyrosine, and motifs 5 and 6 were annotated as putative
epoxide hydrolases. All putative epoxide hydrolase sequences were aligned,
together with the known epoxide hydrolase sequences and a number of known
and putative haloalkane and haloacetate dehalogenases that also belong to the
/-hydrolase fold family and possess an invariable aspartate as the catalytic
nucleophile. The resulting phylogenetic tree was displayed using TreeView and
edited. The multiple sequence alignments were displayed as bit scores for each
position, using the WebLogo sequence generator (http://weblogo.berkeley.edu).
Cloning of epoxide hydrolase genes. Genes encoding putative epoxide hydro-
lases were amplified from respective sources of genomic DNA (see below), using
the primer pairs described in the supplemental material, and subsequently
cloned into the pMAL-c2x plasmid vector. Upon bacterial expression of these
constructs, epoxide hydrolases were obtained as fusion proteins with a maltose
binding protein (MalE) domain linked to the N terminus of the epoxide hydro-
lase domain via a polyasparagine linker and a small decapeptide. The following
DNA sources served as templates: whole-cell material from an overnight culture
(Bsueh, Bfueh1, Npueh1, Npueh2, and Ppueh), genomic DNA added up to 0.05
ng l1 (Draeh, Rpaeh2, Scoeh6, and Tfueh), and plasmid DNA (AraEchA [43],
Coreh [29], and MtuEphF). Primers were used at 0.4 nM in a reaction mixture
with a 0.2 mM concentration of each deoxynucleoside triphosphate and 0.025 U
l1 Pwo DNA polymerase or, in the case of DNAs with high GC contents (see
the supplemental material), 0.05 U l1 Pfu polymerase. The reactions with
high-GC-content DNA were performed in the presence of 5% (vol/vol) dim-
ethyl sulfoxide (DMSO). For genes with no high GC content, the temperature
program used was 15 min at 94°C without polymerase, followed by 30 cycles of
60 s at 94°C, 45 s at 58°C, and 70 s at 72°C and a final step of 4 min at 72°C. For
genes with high GC content, the temperature program used was 15 min at 94°C
without polymerase, followed by 30 cycles of 60 s at 95°C, 45 s at 68°C  0.5°C
cycle1 (each cycle the temperature was lowered 0.5°C), and 120 s at 72°C and
a final step of 4 min at 72°C. For PCR amplification of MtuEphF, the following
program was used: 15 min at 94°C without polymerase, followed by 30 cycles of
60 s at 94°C, 45 s at 50°C, and 70 s at 68°C and a final step of 4 min at 68°C. The
PCR products were digested with various restriction enzymes (see the supple-
mental material for details) and subsequently ligated into BamHI-HindIII-,
EcoRI-HindIII-, EcoRI-PstI-, or XbaI-HindIII-digested pMAL-c2x plasmid
DNA, using T4 DNA ligase. The ligation mixtures were transformed into E. coli
TOP10 cells by electroporation. The transformants were plated on LB medium
containing ampicillin. Colonies were checked for inserts by using PCR with Taq
polymerase and with colony material as the template. Positive colonies were used
to inoculate 5 ml of liquid LB medium and grown overnight at 37°C. Plasmid
FIG. 2. Epoxide substrates used in this study. 1, para-methylstyrene oxide; 2, styrene oxide; 3, para-chlorostyrene oxide; 4, meta-chlorostyrene
oxide; 5, para-nitrostyrene oxide; 6, cis-stilbene oxide; 7, trans-stilbene oxide; 8, chalcone-,-epoxide; 9, phenyl glycidyl ether; 10, para-nitrophenyl
glycidyl ether; 11, epichlorohydrin; 12, epibromohydrin; 13, vinyl oxirane; 14, tert-butyloxirane; 15, 1,2-epoxybutane; 16, 1,2-epoxypentane; 17,
1,2-epoxyhexane; 18, 1,2-epoxyheptane; 19, 1,2-epoxyoctane; 20, cis-2,3-epoxybutane; 21, trans-2,3-epoxybutane; 22, fosfomycin; 23, cyclohexene
oxide; 24, limonene-1,2-epoxide; 25, 3,4-epoxytetrahydrofuran.
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DNA was extracted using a plasmid purification kit from Roche, and the inserts
were sequenced.
Protein expression and purification. Induction conditions for the expression of
fusion proteins were optimized by adding up to 0.4 mM IPTG to a 5-ml culture
with an optical density at 600 nm (OD600) of 0.2, followed by overnight
incubation at various temperatures ranging from 8 to 37°C. The cells were
harvested and resuspended in 0.4 ml TEDANG buffer (20 mM Tris-HCl, pH 7.4,
1 mM EDTA, 1 mM dithiothreitol, 0.02% [wt/vol] NaN3, 200 mM NaCl, 10%
[vol/vol] glycerol) at 4°C. After brief sonication, a cell extract (CFE) was ob-
tained by centrifugation. Cell extracts were analyzed for expression by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis. The levels of expression were
determined from Coomassie-stained gels with the GelPro Analyzer program.
Total protein contents were determined using the Bradford reagent. For Bsueh,
expression was optimized further by transforming the pMAL-c2x-Bsueh con-
struct into E. coli BL21(DE3)/pLysS Rosetta, which has elevated levels of rare
tRNAs that could enhance expression.
Preparative-scale production of proteins was achieved by induction of 1- to
3-liter cultures at an OD600 of 0.2 with 0.4 mM IPTG, followed by overnight
incubation at temperatures ranging from 8 to 30°C. Cells were harvested by
centrifugation, washed, and resuspended in TEDANG buffer at 4°C. The cells
were lysed by sonication, and cell extracts were obtained by centrifugation at
200,000  g for 90 min.
Purification of proteins from CFE was achieved using amylose resin to selec-
tively bind the fusion proteins. Resin with bound fusion protein was subsequently
poured into a column, and after the column was washed with TEDANG buffer,
the fusion protein was eluted with the same buffer containing 10 mM maltose.
Fractions containing active fusion protein were pooled and concentrated. The
protein content of the purified enzyme fractions was determined by A280 mea-
surements. The extinction coefficient was calculated from the amino acid se-
quences of the MalE-EH fusion proteins, using Lasergene-Protean.
Spectrophotometric epoxide hydrolase assays. All continuous spectrophoto-
metric measurements were performed on a Kontron Uvikon 930 UV/VIS spec-
trophotometer. Epoxide hydrolase activities toward para-nitrostyrene oxide
(pNSO; epoxide 5 in Fig. 2) and para-nitrophenyl glycidyl ether (pNPGE; ep-
oxide 10) were determined in 100 mM Tris-SO4 (pH 7.5) as described previously
(43). Errors in values of initial activities calculated from the decrease (pNSO, 310
nm) or increase (pNPGE, 350 nm) in absorbance were 10%, as indicated by
duplicate measurements. The detection limit for these initial activities was 0.002
U mg1 (units are defined in mol min1).
The steady-state kinetic parameters of the purified novel epoxide hydrolases
were determined by measuring progress curves for the conversion of enantiopure
pNSO (epoxide 5) and pNPGE (epoxide 10). The substrate was added at a
concentration of up to 0.5 mM, with a final concentration of DMSO of 1%
(vol/vol). A suitable amount of purified protein was added to start the reaction.
The spectrophotometric conversion traces for the separate enantiomers of ep-
oxides 5 and 10 were directly fitted to Michaelis-Menten kinetics, as described
before, to obtain kcat, Km, and kcat/Km values (36, 43). In case the Km was much
higher than the substrate concentration used, the spectrophotometric traces were
fitted according to first-order kinetics, and the first-order rate constant equals
kcat/Km. In this case, only lower limits of kcat and Km were obtained. More details
on the fitting procedures used can be found in the supplemental material. Errors
in values for kcat, Km, and kcat/Km were 10%, as indicated by duplicate mea-
surements.
Substrate profiling of the various epoxide hydrolases was done using the
adrenaline test (46). Initial testing of various vicinal diols in a reaction with IO4
and adrenaline revealed that adenochrome was rapidly produced with all diols
that are formed from the epoxides shown in Fig. 2, except for diols derived from
glycidyl ethers (epoxides 9 and 10), which do not react fast enough with IO4
(50% conversion in 45 min). Substrates were added at concentrations of up to
1 mM from 50 mM stock solutions in water (epoxide 22) or DMSO (all other
substrates) to 100 l 100 mM sodium phosphate (pH 8.0) in microtiter plates.
Purified protein or CFE was transferred to 100 mM sodium phosphate (pH 8.0)
by desalting over an Econopack desalting column in order to remove compo-
nents that can be oxidized by IO4, such as glycerol and Tris. After 1 h of
incubation of the enzyme with the substrate at room temperature, up to 1 mM
NaIO4 was added from a 10 mM stock solution, and the mixture was incubated
for 45 min, after which L-epinephrine was added to determine the amount of
remaining NaIO4. The A490 value, which is a measure of the amount of adeno-
chrome formed by the reaction with remaining IO4 (46), was determined for
each well. After correction for incubations without substrate but with enzyme
and visual inspection of the microtiter plates, the activities toward the different
substrates were scored as high (, 60 to 100% conversion), intermediate (, 10
to 60% conversion), or low (, 10% conversion).
Kinetic resolution. The enantioselectivities of the enzymes for various ep-
oxides (Fig. 2) were determined by performing a kinetic resolution of 0.5 to 2
mM of racemic substrate in 12 to 20 ml of 100 mM Tris-SO4, pH 7.5, at room
temperature or 30°C. Sampling, chiral gas chromatography (GC), and HPLC
analysis were done as described before (43). The conditions for chiral GC and
HPLC analysis are described in the supplemental material. The E values were
calculated from the resulting data, as described before (26, 43).
Conversion of meso-epoxides. The activities of the expressed epoxide hydro-
lases toward meso-epoxides 20 and 23 were determined at a 2 mM substrate
concentration in 20 ml 100 mM Tris-SO4, pH 7.5. The reaction was started by
adding a suitable amount of CFE or purified enzyme, and samples were taken in
time and extracted with hexane containing an internal standard. The samples were
analyzed by GC (see the supplemental material for the conditions used). Errors in
values of initial activities were 10%, as indicated by duplicate measurements. The
detection limit for these conversions was 0.002 mol min1 mg1.
The diastereomeric composition of the product resulting from the conversion
of epoxide 20 to 2,3-butanediol (diol 20a) was determined by dimethoxypropane
extraction of a 2-ml sample from an incubation of 5 mM of substrate with
enzyme. The organic phase was incubated with Amberlite/H resin for 1 h and
subsequently dried over a short column of anhydrous MgSO4. The same proce-
dure was performed with commercially available reference compounds of the
three different diastereomers of diol 20a. Analysis was done by chiral GC (see the
supplemental material for GC methods).
The diastereomeric composition of 1,2-cyclohexanediol (diol 23a) was deter-
mined by extracting 2 ml of a mixture of 10 mM substrate and enzyme with
diethyl ether. The organic phase was dried over a short column of anhydrous
MgSO4. Commercially obtained samples of the three different diastereomers of
diol 23a were used as reference compounds. Analysis was done by chiral GC (see
the supplemental material for the conditions used).
The E values for the formation of (R,R)- and (S,S)-diols from meso-epoxides






Phylogenetic analysis. To identify the suitability of genomic
sequences as a source of new biocatalytically useful epoxide
hydrolases, we first made an inventory of potential targets for
overexpression in E. coli by screening various eukaryotic and
prokaryotic genome databases for the presence of putative
epoxide hydrolase-encoding sequences. The amino acid se-
quences of epoxide hydrolases for which the activity is known
were used as query sequences. In total, 438 sequenced organ-
isms were screened for the presence of putative epoxide hy-
drolases (Table 1). The obtained hits were manually screened
for the sequence motifs that are characteristic of epoxide hy-
drolases (Fig. 1C) in order to filter out false-positive results.
All sequences that contained the catalytic triad, at least one
ring-opening tyrosine, and the H-G-X-P and G-X-Sm-X-S/T
motifs were annotated as putative epoxide hydrolases. In this
way, 292 amino acid sequences of putative epoxide hydrolases
were identified in 93 different organisms for which no epoxide
hydrolase activity had previously been reported. These se-
quences were subsequently aligned with the amino acid se-
quences of other /-hydrolase fold enzymes that have the
conserved nucleophilic aspartate, including 42 epoxide hydro-
lases with known activity, haloalkane dehalogenases, and flu-
oroacetate dehalogenases. Analysis of the multiple sequence
alignment revealed that 18 hydrolases that were annotated in
the databases as epoxide hydrolases most likely are fluoroac-
etate dehalogenases (see below). The remaining 274 putative
epoxide hydrolases originated from 91 taxonomically different
organisms (Table 1). From this set, 35 sequences were re-
moved before further phylogenetic analysis since they were
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100% identical to sequences from closely related organisms. A
multiple sequence alignment was done with the remaining 239
putative epoxide hydrolases found in sequencing projects, 6
putative epoxide hydrolases from other sources, 42 known ep-
oxide hydrolases, 19 (putative) fluoroacetate dehalogenases,
and 8 (putative) haloalkane dehalogenases.
The database search results showed that 20% of the organ-
isms that have been sequenced thus far contain one or more
putative epoxide hydrolases. However, in some phylogenetic
(sub)classes, such as actinobacteria and fungi, 	50% of the
sequenced organisms contain at least one putative epoxide
hydrolase, whereas in other (sub)classes, such as firmicutes and
chlamydiae, they are hardly present (Table 1). Most microbial
epoxide hydrolases described in the literature originate from
actinobacteria (41) and fungi (39), and their epoxide hydrolase
activity was determined with whole cells (39, 41). Since many of
the sequenced actinobacteria and fungi appear to contain
more than one putative epoxide hydrolase (Table 1), reported
activities and enantioselectivities could well result from more
than one enzyme.
The phylogenetic tree that resulted from the final multiple
sequence alignment identified eight different phylogenetic
groups (Fig. 3). On average, the /-hydrolase fold and cap
domain sequences together (as indicated in Fig. 1C) were 290
to 310 amino acids long (Table 2). In some phylogenetic
groups, the average total sequence length was significantly
larger, which was, in most cases, the result of an N- or C-
terminal extension. The nucleophilic aspartate, the histidine,
and the H-G-X-P and G-X-Sm-X-S/T motifs aligned perfectly
for all sequences. For all putative epoxide hydrolases, two
ring-opening tyrosines were identified in the cap domain. The
position of the first tyrosine (Y152 in EchA) (Fig. 1) especially
varied considerably between the different groups, but it was
conserved within each group. The charge relay acid was pre-
dominantly an aspartate, usually located at position b (Fig. 1;
Table 2). The average amino acid sequence identity of the
complete sequences was only 14%, or 19% if only sequences
with known activity were included, so a low sequence identity
appears to be normal for this class of enzymes. The relatively
long nodes compared to the branches of the phylogenetic tree
also indicate low overall identity, even within a group (20 to
35%) (Fig. 3). Apparently, only a few residues are crucial for
proper performance of the various enzymes, and the overall
/-hydrolase fold and active-site geometry allow significant
sequence variation, as observed in previous studies on phylo-
genetic relationships between functionally different /-hydro-
lase fold enzymes (8, 9). This is most strikingly demonstrated
by the fact that the amino acid sequences of the epoxide hy-
drolases from A. radiobacter AD1 (35) and A. niger (3) are
10% identical, but the /-hydrolase fold part of their X-ray
structures and their active sites are virtually superimposable
(31, 51). Most of the phylogenetic groups of epoxide hydro-
lases consist of homologs from evolutionarily very distant or-
ganisms. Since the overall identity within each group is rather
low, and since the high identities that do occur are between
enzymes that originated from closely related organisms, the
majority of these genes are probably orthologs that were sep-
arated during speciation. Since bacteria are biased toward de-
leting genes that are no longer needed (28), several specialized
microorganisms such as lactic acid bacteria probably lost their
epoxide hydrolase genes during evolution. Indeed, most ep-
oxide hydrolases occur in organisms with large genomes (	8
Mb), even though the size of their collective genomes is similar
to that of the small-genome organisms (2 Mb) (Fig. 4). Lat-
eral transfer may play a role in some cases, as suggested by the
situation encountered in Mycobacterium tuberculosis, which con-
tains 11 /-fold hydrolases (3 dehalogenases and 8 epoxide
hydrolases) in a 4-Mb genome that harbors less than 4,000
genes in total.
In order to investigate whether the phylogenetic study per-
formed here was biased by the available sequenced genomes, a
BLAST search with the same 42 query sequences of epoxide
hydrolases with known activity was done on the open reading
frames that were identified in the Sargasso Sea environmental
TABLE 1. Epoxide hydrolases in various classes of sequenced organisms
Domain Class No. of organismssequenced
No. of organisms in
which an EH(s) was
detecteda
Avg no. of EHs per
EH-containing strainb Subclass(es) with many EHs
No. of EHs used
in alignment c
Archaea 24 1 (4) 1 (1) 1
Bacteria Actinobacteria 30 18 (60) 5 (1–11) Mycobacteria, Streptomycetes 67
Chlamydiae 11
Cyanobacteria 16 7 (44) 1.6 (1–3) 11
Firmicutes 103 2 (2) 1 (1) 2
-Proteobacteria 39 12 (31) 3.3 (1–12) Rhizobiaceae 41
-Proteobacteria 25 12 (48) 3.3 (1–9) Burkholderiaceae 38

-Proteobacteria 8 1 (13) 1 (1) 2
ε-Proteobacteria 6
-Proteobacteria 91 8 (9) 2.9 (1–7) Pseudomonadaceae 24
Spirochaetales 6 1 (17) 3 (3) 3
Others 30 4 (13) 1.5 (1–2) 13
Eukaryota Fungi/metazoa 37 21 (57) 2.5 (1–10) Ascomycota 59
Others 10 4 (40) 2.5 (1–4) 26
a The percentage of epoxide hydrolase-containing organisms within each class is indicated in parentheses.
b The range of putative epoxide hydrolase genes per strain is indicated in parentheses.
c Including known epoxide hydrolases.
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genome sequencing project (44). In total, 61 complete putative
epoxide hydrolase sequences were retrieved, which were all
different from the 42 known epoxide hydrolases. A multiple
sequence alignment including the 61 environmental sequences
yielded the same eight phylogenetic groups. Most of the envi-
ronmental sequences clustered either with other environmen-
tal sequences or with putative epoxide hydrolases from Burk-
holderia spp., which are very abundant in the Sargasso Sea (44).
Since many of the sequences retrieved from the Sargasso Sea
probably are missing part of their N and/or C terminus, they
were not included in further phylogenetic studies.
Characteristics of phylogenetic groups. The members of
phylogenetic group 1 epoxide hydrolases originated predomi-
nantly from proteobacteria (	70% of the group members).
This group includes an epoxide hydrolase that was recently
identified in an environmental gene library (49). The members
of subgroup 1A are, on average, 40 amino acids longer than the
other members of this group. Using SignalP software (http:
//www.cbs.dtu.dk/services/SignalP), these extra amino acids
were identified as an N-terminal signal peptide for protein
excretion. A more thorough analysis of the various character-
istic signal peptide regions suggested that these proteins are
secreted via a twin arginine translocation pathway (1). This
pathway usually translocates completely folded proteins, in-
cluding cofactor-dependent enzymes, across cellular mem-
branes (14).
Group 2 contains epoxide hydrolases from bacterial, archaeal,
and eukaryotic origins. Some of the eukaryotic epoxide hydro-
lases originated from multicellular organisms. Thus far, only two
classes of eukaryotic epoxide hydrolases from multicellular organ-
isms are known, which are the microsomal/juvenile hormone ep-
oxide hydrolases (group 5) and the cytosolic/plant epoxide hydro-
lases (group 8). The putative eukaryotic epoxide hydrolases that
cluster in group 2 have an N-terminal extension of unknown
function and are therefore somewhat longer than the enzymes in
this group that are of prokaryotic origin (Table 2). Group 2
contains a relatively large number of putative epoxide hydrolases
that originated from cyanobacteria (20%).
Group 3 consists predominantly of putative epoxide hydro-
lases from actinobacteria, -proteobacteria, and fungi. About
FIG. 3. Phylogenetic tree of /-hydrolase fold enzymes with a nucleophilic aspartate. Symbols: F, enzymes for which an epoxide hydrolase
function is described in the literature or databases; E, enzymes identified in this study and active with one or more epoxides; , putative epoxide
hydrolases for which no epoxide substrate was found. The black nodes are (putative) epoxide hydrolases, red nodes are (putative) haloacetate
dehalogenases, green nodes are (putative) haloalkane dehalogenases, and orange nodes in group 3 are putative epoxide hydrolases with a
C-terminal part that is homologous to short-chain dehydrogenase/reductase family proteins (SDR proteins). Groups 1 to 8 are described in Table
2.
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one-third of the group members consist of an epoxide hydrolase
domain (N-terminal) and a C-terminal domain that is homolo-
gous to SDR proteins (Table 2). The epoxide hydrolase domain
of the fungal epoxide hydrolase sequences is, on average, 34
amino acids longer than that of the other group members.
In group 4, both epoxide hydrolases and haloalkane deha-
logenases appear to be present (Fig. 3; Table 2). These struc-
turally related enzymes, which also have similar mechanisms
(2), can be distinguished at the amino acid level by the pres-
ence of the ring-opening tyrosines, which are missing in the
haloalkane dehalogenases. Since these tyrosines do not always
align perfectly, the H-G-X-P motif, which is located between
sheet 3 and helix 1 (Fig. 1), is more suitable for distinguish-
ing epoxide hydrolases from haloalkane dehalogenases. The
main chain amide of the X residue is part of the oxyanion hole
in both enzyme classes (Fig. 1B). The side chain is part of the
wall of the active site and can therefore interact with the
substrate (31, 51). In epoxide hydrolases, the X residue is
always an aromatic amino acid, whereas in haloalkane deha-
logenases it is a more hydrophilic or even charged residue such
as asparagine or glutamate (Fig. 5A). Although the exact func-
tion of the motif is unknown, it can possibly be used to distin-
guish between epoxide hydrolases and haloalkane dehaloge-
nases. The fungal enzymes present in this group consist
predominantly of homologous epoxide hydrolase sequences of
various Saccharomyces spp. (Fig. 3).
More than half of the 42 known epoxide hydrolases that
were included in the multiple sequence alignment clustered in
group 5 (Fig. 3; Table 2). This group includes the well-known
mammalian microsomal epoxide hydrolases (22) and the juve-
nile hormone epoxide hydrolases that are present in many
insects (18). Group 5 is the best-defined group in the phylo-
genetic tree (Fig. 3). Its members are, on average, 100 (bacte-
rial), 120 (fungal), and 150 (higher eukaryotes) amino acids
longer than most other epoxide hydrolases (Table 2), which is
mainly due to a large N-terminal extension. The mammalian and
insect epoxide hydrolases of this group are membrane bound by
an N-terminal membrane anchor (20). The fungal and bacterial
epoxide hydrolases of this group do not contain this membrane
anchor and are therefore probably soluble. The N-terminal ex-
tension is important for the phylogenetic distinction of the group
TABLE 2. Phylogenetic groups of /-hydrolase fold enzymes with a nucleophilic aspartate
Groupa Source(s) Activity (putative) No. of members(known, new)








1 Bacterial, fungal Epoxide hydrolase 22 (1, 0) BD8876 (49) D (b) (100) 300
1A Bacterial Epoxide hydrolase 12 (0, 0) D (b) (100) 344
2 Bacterial, archaeal Epoxide hydrolase 26 (0, 3) Bsueh, Draeh, Npueh 1 D (b) (100) 295
Nematode 4 (0, 0) 367
3 Fungal Epoxide hydrolase 11 (0, 0) D (b) (100) 342
Bacterial Epoxide hydrolase 12 (0, 0) 313
Epoxide hydrolase-SDR 12 (0, 0) 591
4 Bacterial Epoxide hydrolase 27 (0, 1) Npueh2, Ppueh D (b) (100) 308
Fungal Epoxide hydrolase 6 (0, 0) 295
Bacterial Haloalkane
dehalogenase
8 (5, 0) Xanthobacter autotrophicus DhlA
(23)
D (b) (50), E (a) (50) 299
5 Animal Epoxide hydrolase 19 (13, 0) Human micosomal EH (22),
Manduca sexta juvenile hormone
EH (18)
D (b) (25), E (b) (75) 459
Fungal 22 (6, 0) A. niger EH (3), R. glutinis EH (45) 418
Bacterial 44 (4, 1) BD9883 (49), Bfueh1 399
6 Bacterial, fungal Epoxide hydrolase 14 (2, 0) Corynebacterium sp. strain C12 EH
(29), BD8877 (49)
D (a) (64), E (a) (36) 293
Bacterial Haloacetate
dehalogenase
19 (1, 0) Moraxella sp. DehL (24) D (a) (100) 297
7 Bacterial Epoxide hydrolase 4 (2, 0) Agrobacterium radiobacter AD1 EH
(35), BD10721 (49)
D (b) (100) 292
8 Animal Epoxide hydrolase 4 (3, 0) Human soluble EH (10) D (b) (100) 549
Plant 15 (11, 0) Potato EH (40) 337
Bacterial 26 (0, 1) Rpaeh2 329
a Phylogenetic group, as depicted in Fig. 3.
b As depicted in Fig. 1.
FIG. 4. Occurrence of putative epoxide hydrolases in prokaryotes
and archaea in relation to genome size. The number of organisms with
a given genome size is indicated above each percentage bar, with the
size of the collective genomes in this category shown in parentheses (in
Mb). The percentages of organisms that have at least one putative
epoxide hydrolase are indicated in black. The horizontal line indicates
the average number of epoxide hydrolase-containing organisms
(17.5%).
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5 epoxide hydrolases from all others, but the differences are also
clearly present in the /-hydrolase main domain. In contrast to
the case for most epoxide hydrolases, the charge relay acid in this
group of epoxide hydrolases is a glutamate in 75% of the cases
instead of an aspartate (Table 2).
Group 6 contains both fluoroacetate dehalogenases and ep-
oxide hydrolases. For all members of this group, the charge
relay aspartate is located at position a instead of the more
common position b (Fig. 1; Table 2). The putative fluoroac-
etate dehalogenase sequences all grouped together with the
fluoroacetate dehalogenase from Moraxella sp. (24) (Fig. 3).
These sequences contain three consecutive arginines distal
from the nucleophilic aspartate in a DRXXRXXXR motif,
whereas epoxide hydrolases usually have a conserved aromatic
residue distally flanking the catalytic nucleophile (Fig. 5B). It
was proposed that one of these arginines plays a role in the
binding of the acid part of the fluoroacetate substrate (25).
Furthermore, all of these sequences have the fluoroacetate
dehalogenase from Moraxella sp. (24) as their highest scoring
BLAST hit for proteins that have known activity. These puta-
tive haloacetate dehalogenases have often erroneously been
annotated as epoxide hydrolases, including in a recent phylo-
genetic study of epoxide hydrolases (9). The presence of a
conserved tyrosine in the cap domains of haloacetate dehalo-
genases that aligns perfectly with one of the ring-opening ty-
rosines of epoxide hydrolases contributes to the confusion. The
epoxide hydrolase sequences in group 7 are similar to those in
group 6. The first conserved ring-opening tyrosine and the charge
relay aspartate, however, are located at different positions (Fig. 1;
Table 2).
Group 8 contains a large number of known epoxide hydro-
lases from plants and mammals, including the well-known
mammalian cytosolic epoxide hydrolases (Fig. 3; Table 2).
There are no sequences originating from other, lower eukary-
otic organisms, such as fungi, in this group. The plant epoxide
hydrolases occur only in this group. The cap domain of this
group of epoxide hydrolases has a 30-amino-acid excursion
between helixes 6 and 7 (Fig. 1), resulting in a larger size of
the epoxide hydrolase segment (Table 2).
Overexpression and purification of putative epoxide hydro-
lases. Ten putative epoxide hydrolase-encoding genes from
different phylogenetic groups and the bacterial epoxide hydro-
lases from A. radiobacter (35) (AraEchA) and Corynebacterium
sp. strain C12 (29) (Coreh) were selected to be cloned and
overexpressed in E. coli (Table 3). Since initial attempts to
overexpress the epoxide hydrolases from Mycobacterium tuber-
culosis H37v (MtuEphF) and Pseudomonas putida KT2440
(Ppueh) in E. coli using the pGEF system (38) resulted in
inclusion bodies (data not shown), it was decided to overex-
press the enzymes as maltose binding protein-epoxide hydro-
lase fusion proteins (MalE-EH). The MalE tag was expected to
facilitate proper folding of the epoxide hydrolased in E. coli
(37). Moreover, it serves as a convenient purification tag. The
MalE-EH fusion proteins were produced in E. coli at levels of
10 to 60% of the total soluble protein in CFEs, including the
enzymes for which expression yielded inclusion bodies when no
MalE was fused to the epoxide hydrolase (Table 3). The CFE
prepared from an expression culture of the MalE-Bsueh (orig-
inating from Bacillus subtilis) construct in E. coli TOP10 cells
resulted in rather low specific activities (0.03 mol min1
FIG. 5. Multiple sequence alignments of conserved regions in functionally different /-hydrolase fold enzymes, represented as bit scores for
each position, with the total height indicating the degree of conservation (maximum level, 4.32) and the relative heights of different symbols at the
same position indicating the frequencies of the amino acids at that position. (A) H-G-X-P region in epoxide hydrolases and haloalkane
dehalogenases. (B) Region around the nucleophilic aspartate in epoxide hydrolases and fluoroacetate dehalogenases.
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mg1), possibly due to poor expression levels caused by the
large number of rare codons present in the Bsueh gene. Ex-
pression of the MalE-Bsueh protein in E. coli BL21(DE3)/
pLysS Rosetta, an E. coli variant that has increased levels of
rare tRNAs, resulted in a twofold improvement in specific
activity in the cell extract.
Amylose resin purification was first tested with the MalE-
Coreh construct, resulting in 10 mg of 83% pure fusion protein
from a 1-liter culture at an OD600 of 1.5, with a total activity
yield of 84%. The MalE-EH fusion proteins of the three ep-
oxide hydrolases from phylogenetic group 2 (Fig. 3; Table 2)
were also produced at a preparative scale and conveniently
purified from cell extracts using the MalE tag. The enzymes
from Deinococcus radiodurans (Draeh) and Nostoc punctiforme
(Npueh1) were obtained at 	95% purity with good yields. The
B. subtilis enzyme could only be obtained at 50 to 70% purity
with a single round of amylose resin purification. The enzyme
was unstable under the purification conditions used and was
therefore not purified further (see the supplemental material
for details on enzyme purifications).
Activity of MalE-epoxide hydrolase fusion proteins. CFEs
and/or purified samples of the MalE-EH fusion proteins were
tested for activity towards a range of epoxides, using either a
colorimetric assay (substrates 5 and 10) (Fig. 2) or an indirect
assay that measures periodate depletion by its reaction with a
diol (substrates 1, 2, 4, 7, 8, 11 to 14, 16, 17, and 19 to 25). In
the latter assay, the diol that is formed by epoxide hydrolase
activity reacts with periodate, and the amount of remaining
periodate is measured by incubating it with adrenaline to yield
a colored product (46). Using these assays, it appeared that of
the 12 epoxide hydrolases that were tested, 8 were active with
one or more epoxides (Table 4). The substrate ranges of the
enzymes were generally very broad and included styrene oxide
derivatives, phenyl glycidyl ethers, and most terminal aliphatic
epoxides. Only a few enzymes showed activity with the steri-
cally more demanding ,-disubstituted epoxides (compounds
6 to 8, 20, 23, and 24). Among the proteins for which no activity
was detected were MtuEphF and Ppueh. It is likely that the
inactive proteins were correctly folded since they were ex-
pressed as soluble proteins. Activity was detected with proteins
from different groups, and in combination with data in the
literature, it was concluded that epoxide hydrolases occur in at
least seven of the phylogenetic groups described above (Fig. 3;
Table 2). The fact that Npueh2 is active toward pNPGE (com-
pound 10) (Tables 3 and 4) shows that group 4 contains both
haloalkane dehalogenases and epoxide hydrolases (Fig. 3). The
nature of residue X in the H-G-X-P motif (motif 5 in Fig. 1),
as described above, could indeed be used for distinction be-
tween the two functional classes (Fig. 5A).
The epoxide hydrolase from Rhodopseudomonas palustris
(Rpaeh2), which belongs to group 8 (Table 2), was active
toward trans-stilbene oxide (compound 7) but not toward cis-
stilbene oxide (compound 6) (Table 4). Both the mammalian
and the plant soluble epoxide hydrolases, which also belong to
phylogenetic group 8, have the same characteristic (11, 19, 30).
Thus, this particular cis versus trans specificity is clearly linked
to phylogenetic group 8. The three-dimensional structure of
mammalian sEH, a group 8 member, revealed an L-shaped
substrate access tunnel with the catalytic nucleophile sitting
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other EH structures, where the catalytic nucleophile sits at the
very end of the substrate access tunnel, the particular active-
site architecture of sEH, and possibly of the other group 8
members, does indeed favor the turnover of trans-1,2-disubsti-
tuted epoxides.
An analysis of the genes carried in the vicinity of the six
putative epoxide hydrolase genes for which activity was found
did not clearly reveal a function for the enzymes. However, the
genes encoding the epoxide hydrolases from B. subtilis, Burk-
holderia fungorum (Bfueh1), and R. palustris are located near
genes encoding putative enzymes that may be involved in the
detoxification of xenobiotics or antibiotics. The genes sur-
rounding the epoxide hydrolase genes from D. radiodurans and
N. punctiforme are of unknown or unrelated function. Thus,
the biological function of the epoxide hydrolases identified
here is uncertain.
Enantioselectivity and unusual enantiopreference of group
2 enzymes. The enantioselectivity of the active epoxide hydro-
lase fusion proteins was tested with various chiral substrates.
The enantioselectivities with styrene epoxides and phenyl gly-
cidyl ethers were generally low (E  10) to modest (10  E 
50) (Tables 3 and 5). This could possibly be influenced by the
fact that the tested enzymes were fusion proteins, but the
MalE-AraEchA enzyme showed no reduction in stereospeci-
ficity compared to the native enzyme (43), so in this case the
MalE protein did not influence the catalytic properties of the
enzyme. The highest E values were found for para-nitrostyrene
oxide, using the D. radiodurans enzyme (Draeh), and for para-
nitrophenyl glycidyl ether, using the B. subtilis epoxide hydro-
lase (Bsueh).
Most well-described epoxide hydrolases, such as the ones
from A. radiobacter AD1 (43), A. niger (16, 32), and Rhodo-
thorula glutinis (47) and the mammalian microsomal epoxide
hydrolase (13), are (R) specific toward styrene oxides and (S)
specific toward phenyl glycidyl ethers. In contrast, Bsueh,
Draeh, and Npueh1 (from N. punctiforme) had an opposite
enantiopreference towards these compounds. The enantio-
selectivities varied from low (E  10) to intermediate (10 
E  50) and were generally higher for the aromatic substrates
(epoxides 1 to 5, 9, and 10). All three of these epoxide hydro-
lases belong to phylogenetic group 2 (Fig. 3; Table 2). Of these
three proteins, the B. subtilis enzyme has the most restricted
substrate range. The enzyme had reasonable activities toward
the terminal epoxides pNPGE (compound 10) and 1,2-epoxy-
TABLE 4. Substrate ranges of cloned bacterial epoxide hydrolases
Enzyme
Activity toward indicated epoxide substrate numbera:
Aromatic substrates Aliphatic substrates Cyclicsubstrates
1 2 4 5 6 7 8 10 11 12 13 14 16 17 19 20 21 22 23 24 25
AraEchAc                     
Bsuehb                     
Bfuehlc                     
Corehb                     
Draehb                     
MtuEphFc                     
Npueh1b                     
Npueh2c                     
Ppuehc                     
Rpaeh2c                     
Scoeh6c                     
Tfuehc                     
a All assays were done with the adrenaline test (46), with the exception of that for epoxide 10, for which conversion was monitored spectroscopically. Activities were
scored as follows: , 3 nmol mg1 min1; , 	3 nmol mg1 min1; and , 	10 nmol mg1 min1. Epoxide structures are shown in Fig. 2.
b Measurements were performed with purified protein.
c Measurements were performed with desalted cell extracts.
TABLE 5. Activities and enantioselectivities of novel group 2 epoxide hydrolases for terminal epoxides
Enzyme and
parameter
Activity (mol min1 mg1) or enantioselectivitya with indicated epoxide substrate number c:
Aromatic substrates Aliphatic substrates
1 2 3 4 5 9 10 11 15 16 17 18 19
Bsueh
Activity 0.003 0.003 0.003 0.003 0.003 0.01 0.15 0.003 0.003 0.003 0.003 0.11 0.91
Enantioselectivity —b — — — — — 22 (R) — — — — 1.2 (R) 2.5 (R)
Draeh
Activity 0.42 0.06 0.68 0.19 0.11 0.85 0.75 0.07 0.04 0.31 4.3 13.8 25.6
Enantioselectivity 4.2 (S) 5.2 (S) 2.3 (S) 6.4 (S) 21 (S) 1.4 (R) 1.9 (R) 1.3 (S) 2.9 (R) 3.5 (R) 6.5 (R) 4.6 (R) 7.0 (R)
Npueh1
Activity 0.37 0.42 2.1 0.74 1.3 1.3 1.3 0.21 0.33 1.2 1.2 1.7 2.4
Enantioselectivity 2.3 (S) 1.9 (S) 4.6 (S) 1 17 (S) 3.7 (R) 16 (R) 1.3 (R) 1.5 (R) 1.2 (R) 1.7 (R) 1.7 (R) 1.8 (R)
a The preferentially hydrolyzed enantiomer is indicated in parentheses.
b —, activity was too low to determine an accurate E value.
c See Fig. 2 for epoxide structures.
2914 VAN LOO ET AL. APPL. ENVIRON. MICROBIOL.
octane (compound 19), but with substrates that are only a little
smaller (compounds 9 and 18), the activity dropped up to
10-fold. No activity was detectable with epoxides that have only
a short substituent (compounds 11 to 17) and with most sty-
rene oxides (Tables 4 and 5). In contrast, the epoxide hydrolase
from D. radiodurans (Draeh) converted almost all terminal
epoxides that were tested, but of the 1,2-disubstituted ep-
oxides, only trans-stilbene oxide (compound 7) and trans-1,2-
disubstituted chalcone oxide (compound 8) were converted
(Tables 4 and 5). The enzyme prefers terminal epoxides that
have a long substituent, especially unbranched 1,2-epoxyal-
kanes with a long chain length (epoxides 18 and 19). An in-
crease of activity toward unbranched 1,2-epoxyalkanes with
increasing lengths of the side group has also been found with
epoxide hydrolases from R. glutinis and different Rhodothorula
and Trichosporon spp. (15, 48). The epoxide hydrolase from N.
punctiforme (Npueh1) was active not only with all terminal
epoxides that were tested but also with the 1,2-disubstituted
epoxides trans-stilbene oxide (compound 7) and cyclohexene
oxide (compound 23) (Tables 4 and 5). Thus, the activity of
Npueh1 is less influenced by the substituent on the epoxide
ring than that of the Draeh enzyme.
Determination of the steady-state kinetic parameters for
pNSO (compound 5) and pNPGE (compound 10) (Table 6)
revealed that Npueh1 has a rather low Km for either one of
their enantiomers (0.2 mM). Indeed, the kinetic resolution
data for this enzyme for most substrates (Table 5) could only
be fitted when the Km values for the preferred enantiomers
were set lower than 0.2 mM, indicating that this enzyme has a
low Km for the preferred enantiomer with most terminal ep-
oxides. In contrast, with the Draeh enzyme, the Km was far
above the substrate concentration used for pNPGE and pNSO
(	0.5 mM), and the shapes of the kinetic resolution curves
indicate that this is also the case for most other epoxides.
These high Km values indicate that the natural substrate for
Draeh is probably not among the epoxides tested.
The three enzymes from group 2 were found to be (R)
selective with aliphatic terminal epoxides and phenyl glycidyl
ethers but (S) selective toward terminal epoxides with an aro-
matic substituent (Table 5), which makes them the first bacte-
rial epoxide hydrolases that have this uncommon selectivity for
which the genes have been cloned. Also, (S) selectivity toward
meta-chlorostyrene oxide (compound 4) and pNSO (com-
pound 5) and (R) selectivity toward pNPGE (compound 10)
have not been well documented, and the uncommon enantio-
preference of these enzymes widens the scope of bacterial
epoxide hydrolases for the biocatalytic preparation of enantio-
pure epoxides and diols.
Conversion of meso-epoxides. Five of the 12 recombinant
epoxide hydrolases were active toward the meso-epoxides 20
and/or 23 (Table 4). The regioselective conversion of these
(R,S)-configured meso compounds will result in optically en-
riched vicinal diols due to inversion of configuration at one of
the two stereocenters. The activities and enantioselectivities of
the MalE-EH fusion proteins toward meso-epoxides 20 and 23
were determined by following substrate depletion over time
and measuring the enantiomeric composition of the resulting
diol product (Table 7). The activities were rather low for most
substrates (0.05 mol min1 mg1), but the enantiomeric
excess of the product (eep) was in some cases very high
(	95%). With Npueh1, the formation of (1S,2S)-1,2-cyclohex-
anediol from cyclohexene oxide occurred with an eep of	95%,
which is a significant improvement over the 58% eep that was
TABLE 6. Steady-state kinetic parametersa for Draeh and Npueh1
acting on each enantiomer of pNSO (substrate 5)
and pNPGE (substrate 10)
Enzyme and
parameter
Value for indicated enantiomer
(R)-pNSO (S)-pNSO (R)-pNPGE (S)-pNPGE
Draeh
kcat (s
1) 	0.007 	0.17 	0.7 	0.5
Km (mM) 	0.5 	0.5 	0.3 	0.3
kcat/Km (mM
1 s1) 0.020 0.42 2.8 2.1
E valueb 21 (21) 21 (21) 1.3 (1.8) 1.3 (1.8)
Npueh1
kcat (s
1) 	0.2 3.4 	2.6 0.42
Km (mM) 	0.5 0.20 	0.025
c 0.028
kcat/Km (mM
1 s1) 0.60 17 174 15
E valueb 28 (17) 28 (17) 12 (15) 12 (15)
a Since for some enzymes the Km value exceeded substrate solubility, only
lower limits could be determined for kcat and Km, and kcat/Km values were
determined as first-order rate constants.
b Calculated from the kcat/Km ratios of the two enantiomers. The E value
calculated from a kinetic resolution experiment is given in parentheses.
c At higher substrate concentrations, substrate inhibition occurred; therefore,
kcat/Km could be determined only as a first-order rate constant at a low substrate
concentration.
TABLE 7. Activities of different fusion proteins for meso-epoxides
Enzyme
Parameter value for indicated substrate
cis-2,3-Epoxybutane (substrate 20) Cyclohexene oxide (substrate 23)
Activity
(mol min1 mg1) eep (%) E value
d Activity
(mol min1 mg1) eep (%) E value
d
AraEchAa 0.003 85 (2R,3R) 12 0.005 	99 (R,R) 	200
Bfueh1a 0.002 —c — 0.035 89 (S,S) 17
Corehb 0.002 — — 1.4 30 (R,R) 1.9
Npueh1b 0.002 — — 0.016 97 (S,S) 66
Rpaeh2a 0.019 58 (2R,3R) 3.8 0.002 — —
a Initial activities were determined at a 2 mM substrate concentration with cell extracts.
b Activities were measured with (partially) purified protein.
c —, activity was too low to determine the enantiomeric excess of the product (eep).
d The E value was calculated from the eep according to equation 1.
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reported for an epoxide hydrolase (BD10090) obtained from
an environmental gene library (49). Epoxide hydrolases with
excellent enantioselectivities toward meso-epoxides could thus
be obtained from genomic databases.
General conclusions. The results reported here indicate that
epoxide hydrolase genes that encode active proteins are widely
present in microbial genomes. In about 20% of the organisms
for which the whole genome sequence is known, putative ep-
oxide hydrolase genes are present, and the expression of a
number of these genes and testing with model substrates iden-
tified activity for 60% of them. Since only a restricted number
of substrates was used, the percentage of organisms that carry
active enzymes is probably larger. Thus far, the functions of
most of these epoxide hydrolases remain unclear.
The various phylogenetic groups of /-hydrolase epoxide
hydrolases harbor orthologs from phylogenetically very differ-
ent organisms. Since the level of sequence identity within the
groups is low, this is probably not caused by recent lateral gene
transfer. A more likely explanation is that the common ances-
tor of epoxide hydrolases was present early in evolution and
widespread among the various species. As a result of specia-
tion, enzymes that cluster in a multiple sequence alignment are
now present in phylogenetically unrelated organisms.
Active recombinant epoxide hydrolases could rapidly be ob-
tained by cloning the genes as fusions to the C-terminal part of
the maltose binding protein (MalE). This facilitated expres-
sion, prevented the formation of insoluble inclusion bodies,
and served as a convenient purification tag. Preliminary exper-
iments showed that the production of soluble protein failed for
only 2 of the 12 enzymes that were synthesized as fusion pro-
teins. This approach for obtaining new enzymes for biocatalysis
is attractive since the gene of a positive hit is immediately
available for further improvement by site-directed mutagenesis
or directed evolution.
The cloning and characterization of the putative epoxide
hydrolases led to several new active enzymes that can be eval-
uated as biocatalysts for enantioselective conversion. Three
enzymes were (S) selective toward aromatic substrates, which
is rather uncommon and has been observed only for a few
other epoxide hydrolases (21, 27, 42, 50). Furthermore, the
enzymes from B. fungorum (Bfueh1) and N. punctiforme
(Npueh1) converted the prochiral substrate cyclohexene oxide
to optically enriched (1S,2S)-1,2-cyclohexanediol with much
higher enantioselectivities than previously reported (Table 7)
(49). Thus, new epoxide hydrolases with interesting biocata-
lytic activities can be obtained using genomic databases, which
defines genome analysis as a promising strategy to widen the
scope of biocatalysts, as previously shown for carbohydrate-
converting enzymes (17).
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